81.7% of patients were on an SGLT2 inhibitor 74.7% of patients were on an ARNI 95.1% of patients were on a beta-blocker 83.1% of patients were on an MRA Despite high use of GDMT, the rate of ...

Pfizer’s sickle cell disease (SCD) drug has flunked a key phase 3 test, the latest blow to the pharma’s $5.4 billion acquisition of Global Blood Therapeutics. Pfizer acquired the P-selectin inhibitor, ...

New Hampstead's Gianna Brown, who excelled in flag football, basketball, volleyball and soccer for the Phoenix, was named the winner of the 33rd annual Hollis Stacy Award as the most versatile female ...

The nominees for the 33rd annual Hollis Stacy Award have been announced by Award Director Leslie Moses. The award recognizes the most versatile female high school athlete in Savannah. To be eligible ...

Heightened market volatility presents unique buying opportunities for income investors, particularly in the technology and energy sectors, which show signs of bottoming as Q1 earnings season ...

SCD, a global leader in defense technology specializing in the development and manufacture of a wide range of cooled and uncooled infrared detectors and high-power laser diodes, announces significant ...

LMP Capital and Income Fund offers an 8% dividend yield, focusing on income through diverse investments in MLPs, REITs, and common stocks. SCD's strategy includes a mix of energy and tech stocks, ...

SAN DIEGO — Significant complications were common in female patients with sickle cell disease (SCD) who underwent fertility preservation (FP) procedures, and 13% required multiple retrieval cycles, a ...

The 2024 Update of the World Bank Group Croatia Systematic Country Diagnostic is now published. The 2024 SCD is an update of the 2018 edition, the first SCD produced for Croatia. This 2024 SCD Update ...

With nearly a century of postseason failures at their heels and a daunting 3-0 deficit to the New York Yankees in the ALCS ahead of them, the 2004 Boston Red Sox accomplished what no franchise had ...